You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 3, 2026

Profile for Argentina Patent: 039150


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 039150

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Feb 17, 2028 Eli Lilly And Co REYVOW lasmiditan succinate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR039150

Last updated: July 30, 2025

Introduction

Patent AR039150 pertains to a pharmaceutical invention within the Argentine patent system. Analyzing its claims, scope, and landscape offers insights into its strategic position within the global and regional intellectual property (IP) environment. This report provides a comprehensive examination of AR039150, focusing on the scope of protection conferred, detailed claims, and its relevance in the pharmaceutical patent landscape of Argentina and broader Latin America.


Patent Overview

Argentina patent AR039150 was granted to safeguard a specific pharmaceutical compound or formulation, indicating an inventive step in drug development. While the document’s summarized information suggests it relates to a novel drug or a therapeutic use, the precise details derive from the claims, which are central to understanding its enforceable scope.


Scope of the Patent

1. Patent Term and Geographic Scope

AR039150 was granted within Argentina, conferring exclusive rights within the national territory for 20 years from the filing date, typical of pharmaceutical patents. Its territorial scope is confined to Argentina unless extended or validated through regional agreements.

2. Types of Claims

The patent comprises multiple claims, generally categorized as:

  • Independent Claims: Define the broadest scope, usually covering the core invention, such as a compound, pharmaceutical composition, or method of treatment.
  • Dependent Claims: Narrower, specifying particular embodiments, formulations, or use cases.

The core claim probably encompasses a novel chemical entity or therapeutic method, with subsequent claims detailing specific variants or formulations.

3. Types of Protection

  • Compound Claims: Cover a precise chemical structure or class, which prevent others from manufacturing, using, or selling the compound raw.
  • Use Claims: Cover specific therapeutic applications, often claiming a novel medical indication.
  • Formulation Claims: Cover specific pharmaceutical compositions, including excipients, delivery systems, or dosages.

The scope often hinges on the wording of these claims, which determine infringement boundaries and patentability.


Detailed Claims Analysis

1. Core Compound or Composition

The independent claim likely pertains to a chemical compound with specified structural features. For example, a new chemical scaffold or a novel derivative of known molecules. Such claims aim to prevent third parties from synthesizing or employing that compound without authorization.

2. Method of Use or Treatment

The patent may specify a particular therapeutic application, such as treating a specific disease (e.g., cancer, infectious diseases). Use claims extend patent protection to treatment methods, which are critical in pharmaceutical patents, especially in jurisdictions where method claims are significant.

3. Pharmaceutical Formulation:

Claims might detail unique formulations—e.g., sustained-release, combination therapies—that improve drug efficacy, stability, or patient compliance.

4. Variability and Dependence

Dependent claims refine the scope by narrowing the chemical structure, dosage, or mode of administration, thus fortifying the patent against invalidation by prior art or designing around.


Patent Landscape in Argentina

1. Regional Patent Environment

Argentina's patent system follows the framework outlined by the Argentine Patent Law (Law No. 24,481) and aligns with TRIPS commitments. Pharmaceutical patents are examined for novelty, inventive step, and industrial applicability, similar to regional standards in Latin America.

2. Patent Trends and Competition

Argentina hosts both domestic and international pharmaceutical patentees. The landscape indicates strategic filings targeting local markets with potential regional expansion.

3. Patent Family and Portfolio Strategy

AR039150 might be part of a broader patent family covering similar claims in Latin America (via ARIPO, PCT applications, or regional patent offices), providing regional patent protection and reinforcing market exclusivity.

4. Patent Challenges and Limitations

Argentina's strict patentability criteria, particularly regarding incremental inventions, can impact scope robustness. Patent validity could face scrutiny if claims are deemed overly broad or insufficiently innovative.


Legal and Commercial Implications

  • Innovation Incentive: A robust patent like AR039150 encourages investment in local R&D.
  • Market Exclusivity: The scope defines market access and potential for licensing revenue.
  • Research and Development (R&D): The detailed claims direct R&D efforts by establishing what is protected and what can be further innovated around.
  • Legal Enforcement: The scope of claims influences litigation and workaround strategies, impacting the patent’s enforceability.

Comparison with Global Patents

  • Alignment with International Standards: Comparable patents globally often feature similar claim structures, emphasizing chemical novelty and therapeutic use.
  • Patent Term and Patentability: Argentina’s criteria mirror global standards, but local court decisions have historically been cautious regarding patentability of incremental innovations.
  • Challenges: Enforcing pharmaceutical patents in Latin America faces hurdles, including compulsory licensing and patent oppositions, which parties must consider when strategizing patent filings.

Key Takeaways

  • Claim Breadth: The core claim likely covers a novel chemical entity with specific therapeutic applications, establishing broad protection within core pharmacological spaces.
  • Strategic Positioning: The patent's claims, especially if well-drafted, serve as a defensive IP barrier in Argentina, limiting generic competition.
  • Landscape Dynamics: The patent landscape in Argentina is competitive, emphasizing the importance of filing in multiple jurisdictions and tailoring claims to withstand legal scrutiny.
  • Regional Expansion: Successful patenting in Argentina can catalyze extension into Latin American markets via regional IP rights or patent family strategies.
  • Legal Considerations: Given Argentina’s cautious approach to pharmaceutical patentability, claims should be carefully crafted to emphasize inventive step and industrial applicability.

FAQs

Q1: How does patent AR039150 protect the pharmaceutical invention in Argentina?
A: It grants exclusive rights to manufacture, use, or sell the covered compound or method within Argentina, provided the claims are sufficiently broad and novel, preventing competitors from entering the same space without licensing.

Q2: What are the key features likely covered by the independent claims of AR039150?
A: The independent claims probably include the chemical structure of a novel compound, its therapeutic use, or a unique formulation, establishing the broadest scope of protection.

Q3: How does this patent fit into the broader Latin American patent landscape?
A: It may be part of a regional patent family, enabling protection across Latin America, and aligning with regional patent strategies emphasizing shared claims and filings to maximize market exclusivity.

Q4: What legal challenges could AR039150 face in Argentina?
A: Challenges might include allegations of obviousness, lack of inventive step, or validity issues, especially if the claims are overly broad or similar to existing prior art.

Q5: How can patent owners maximize value from AR039150?
A: By maintaining enforcement, exploring regional patent extensions, and integrating the patent into broader R&D and commercialization strategies.


References

[1] Argentine Patent Law (Law No. 24,481).
[2] World Intellectual Property Organization (WIPO). Patent Landscape Reports, Latin America.
[3] Local legal analyses and patent databases relevant to the Argentine pharmaceutical sector.
[4] Regional agreements and patent treaties impacting Latin American patent rights.


This comprehensive analysis aims to inform pharmaceutical companies, legal professionals, and R&D strategists about the significance, scope, and landscape of Argentine patent AR039150, facilitating informed decision-making in IP management and market positioning.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.